CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
this is a trial evaluating three chemotherapy agents in patients with newly diagnosed ovarian cancer patients that are Stage III or...
Phase 2
Birmingham, Alabama, United States
of olaparib maintenance monotherapy in relapsed high grade serous ovarian cancer (HGSOC) patients (including patients with primary ...
Phase 3
Birmingham, Alabama, United States and 125 other locations
in combination with pembrolizumab versus protocol-specific Investigator's choice chemotherapy in patients with platinum-resistant epithelial ovarian...
Phase 3
Birmingham, Alabama, United States and 118 other locations
of REGN4018 can be given alone or with cemiplimab to patients with ovarian cancer or cancer of the uterus* The study will ...
Phase 1, Phase 2
Birmingham, Alabama, United States and 53 other locations
This is a randomized, open label, multicenter trial to evaluate the safety, dosing, efficacy and biological activity of intraperitoneal IMNN-001 plus...
Phase 1, Phase 2
Birmingham, Alabama, United States and 20 other locations
of sovilnesib at different dose levels to establish the Recommended Phase 2 Dose (RP2D) of sovilnesib in subjects with high grade serous ovarian...
Phase 1
Birmingham, Alabama, United States and 12 other locations
and maintenance olaparib (MK-7339) in women with epithelial ovarian cancer (EOC), fallopian tube cancer, or primary perito...
Phase 3
Birmingham, Alabama, United States and 226 other locations
This study will test the safety of a drug called PF-08046054/SGN-PDL1V alone and with pembrolizumab in participants with solid tumors. It wi ...
Phase 1
Birmingham, Alabama, United States and 43 other locations
This clinical trial is studying advanced solid tumors. Solid tumors are cancers that start in a part of your body like you...
Phase 1
Birmingham, Alabama, United States and 18 other locations
is a type of drug known as a PARP inhibitor. Some types of breast cancer and ovarian cancer share some basic features that...
Phase 2
Birmingham, Alabama, United States and 19 other locations
Clinical trials
Research sites
Resources
Legal